HALOZYME THERAPEUTICS, INC.

By person

25 insiders · 365 transactions

82.5×

Helen I. Torley holds 82.5 times base salary in stock. $82.57M of shares against $1.00M in salary for 2025.

Salary from the company's own proxy. The shares are what Helen I. Torley last reported holding, valued at $107.55, the price Common Stock was last bought or sold at on the open market here, on 11 Sep 2026.

Insider

Role

Bought

Sold

Net

Holding

Of company

Worth

Change

Torley Helen

PRESIDENT AND CEO

—

$96.56M (178) scheduled

−$96.56M

767,780

0.6765%

$82.57M

+568.1%

KIRK RANDAL J

10% owner

—

$61.57M (36)

−$61.57M

5,459,998

4.81%

$587.21M

−48.9%

LaBarre Michael J.

SVP, CHIEF TECHNICAL OFFICER

—

$25.02M (69) scheduled

−$25.02M

173,756

0.1531%

$18.69M

+10.5%

Posard Matthew L.

Director

—

$4.40M (8)

−$4.40M

77,835

0.0686%

$8.37M

−0.5%

LaBrosse Nicole

SVP, CHIEF FINANCIAL OFFICER

—

$3.91M (12) scheduled

−$3.91M

38,494

0.0339%

$4.14M

+664.8%

Kelley Kenneth J

Director

$748.70K (3)

$4.46M (11)

−$3.71M

179,833

0.1584%

$19.34M

−4.5%

Henderson Jeffrey William

Director

—

$3.32M (11)

−$3.32M

36,572

0.0322%

$3.93M

+37.5%

Daly James M

Director

—

$2.29M (4)

−$2.29M

20,503

0.0181%

$2.21M

+1.5%

Caudill Cortney

SVP, CHIEF OPERATING OFFICER

—

$2.23M (4) scheduled

−$2.23M

7,055

0.0062%

$758.75K

−8.1%

MATSUI CONNIE

Director

—

$2.16M (3)

−$2.16M

183,035

0.1613%

$19.69M

−18.0%

BIZZARI JEAN-PIERRE

Director

—

$1.44M (1)

−$1.44M

66,815

0.0589%

$7.19M

+81.5%

Connaughton Bernadette

Director

—

$1.28M (13) scheduled

−$1.28M

40,418

0.0356%

$4.35M

—

Krishnan Mahesh

Director

—

$547.80K (1) scheduled

−$547.80K

14,462

0.0127%

$1.56M

—

Chondros Dimitrios

SVP, Chief Medical Officer

—

$22.18K (1)

−$22.18K

38,584

0.0340%

$4.15M

+13.3%

Stelzer Laurie

SVP, Chief Financial Officer

—

116,167

0.1024%

$12.49M

+1,590%

LEONHARDT HARRY J

SVP, GC

—

66,373

0.0585%

$7.14M

+1,446%

Snyder Mark Howard

SVP, CHIEF LEGAL OFFICER

—

49,929

0.0440%

$5.37M

—

Countouriotis Athena

SVP and Chief Medical Officer

—

39,077

0.0344%

$4.20M

+95.6%

Miyashita Akiko Moni

Director

—

24,937

0.0220%

$2.68M

—

DUNCAN BARBARA GAYLE

Director

—

23,715

0.0209%

$2.55M

—

Matsuda Masaru

SVP, General Counsel

—

20,049

0.0177%

$2.16M

+346.6%

Sun Elaine D

SVP, Chief Financial Officer

—

14,018

0.0124%

$1.51M

—

Hickey Benjamin

SVP, Chief Commerical Officer

—

13,226

0.0117%

$1.42M

—

Lang James Paul

Director

—

4,685

0.0041%

$503.86K

—

RAMSAY DAVID A

EVP, PRESIDENT, DRUG DELIVERY

—

4,592

0.0040%

$493.86K

—

HALOZYME THERAPEUTICS, INC.

By person

Individual transactions

What was left out